This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Donjeta Gjuka: Innovator in Enzyme-Mediated Cancer Treatment
Introduction
Donjeta Gjuka is a prominent inventor based in Austin, TX (US). She has made significant contributions to the field of biochemistry, particularly in the development of methods and compositions for cancer treatment. Her innovative work focuses on enzyme-mediated depletion of adenosine and/or methylthioadenosine.
Latest Patents
Donjeta Gjuka holds 1 patent for her invention titled "Enzyme-mediated depletion of adenosine and/or methylthioadenosine." This patent describes methods and compositions related to engineering a protein with MTA/ADO-degrading enzyme activity. The invention includes an MTase capable of degrading MTA/ADO, providing potential therapeutic applications for cancer or severe combined immunodeficiency (SCID) using the disclosed proteins or nucleic acids.
Career Highlights
Donjeta Gjuka is affiliated with the University of Texas System, where she continues her research and development in biochemistry. Her work has garnered attention for its potential impact on cancer treatment and related fields.
Collaborations
One of her notable collaborators is Everett Stone, who works alongside her in advancing their research initiatives.
Conclusion
Donjeta Gjuka's innovative contributions to enzyme-mediated cancer treatment highlight her role as a leading inventor in the field. Her work promises to pave the way for new therapeutic strategies in combating cancer and related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile